Application Sponsors
NDA 020525 | BAYER HEALTHCARE LLC | |
Marketing Status
Application Products
001 | TABLET;VAGINAL | 200MG | 1 | GYNE-LOTRIMIN 3 | CLOTRIMAZOLE |
FDA Submissions
TYPE 8; Type 8 - Partial Rx to OTC Switch | ORIG | 1 | AP | 1996-07-29 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 2 | AP | 1998-03-17 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 3 | AP | 1999-12-13 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 4 | AP | 2000-09-01 | STANDARD |
Submissions Property Types
SUPPL | 1 | Null | 0 |
SUPPL | 2 | Null | 0 |
SUPPL | 3 | Null | 0 |
SUPPL | 4 | Null | 0 |
CDER Filings
BAYER HEALTHCARE LLC
cder:Array
(
[0] => Array
(
[ApplNo] => 20525
[companyName] => BAYER HEALTHCARE LLC
[docInserts] => ["",""]
[products] => [{"drugName":"GYNE-LOTRIMIN 3","activeIngredients":"CLOTRIMAZOLE","strength":"200MG","dosageForm":"TABLET;VAGINAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"GYNE-LOTRIMIN 3","submission":"CLOTRIMAZOLE","actionType":"200MG","submissionClassification":"TABLET;VAGINAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)